Search results
Pfizer's Nearly $7 Billion Acquisition Of Arena Pharma Just Paid Off In A Big Way
Investor's Business Daily· 2 years agoPfizer's nearly $7 billion takeover of Arena Pharmaceuticals looked prescient Tuesday after the...
Better Bull Market Buy: Novavax vs. Pfizer
Motley Fool via Yahoo Finance· 3 months agoIt's official: The S&P 500 is in a bull market after reaching a new all-time high last month. The index actually has been in this positive market phase...
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
Motley Fool· 6 months agoPfizer's (NYSE: PFE) stock performance has been disappointing this year (down 38%). For example,...
Is Pfizer Stock a Buy in 2024?
Motley Fool via Yahoo Finance· 4 months agoIf you're in the process of rebalancing your portfolio, you might be considering buying Pfizer (NYSE: PFE) stock. After all, the drugmaker pays a...
Is Pfizer Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 2 months agoThe stock market is at record levels these days, but one company that isn't reflecting that optimism is Pfizer (NYSE: PFE). Shares of the pharma giant...
Where Will Pfizer Be in 5 Years?
Motley Fool· 7 months agoPfizer (NYSE: PFE) is a company that's in the midst of a transition. The COVID-19 vaccine maker benefited from a huge revenue boost due to the pandemic....
Why Pfizer Likely Isn't Done With M&A After the Seagen Deal
Motley Fool· 1 year agoPfizer (NYSE: PFE) has been a company on a mission, looking to restock its pipeline with growth...
Pfizer (PFE) Cuts 2023 Outlook as COVID Products' Demand Falls
Zacks via Yahoo Finance· 7 months agoPfizer PFE slashed its previously issued revenue guidance for 2023 due to lower-than-expected demand...
Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod
Zacks via Yahoo Finance· 3 months agoPfizer PFE announced that the European Commission has granted marketing approval to its oral,...
Pfizer buying spree continues with $5.4B hematology deal
Associated Press via Yahoo News· 2 years agoPfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant...
